To explore the e¡ect of G72/G30 polymorphisms on the clinical manifestations of schizophrenia, especially on the age at onset and sex of patients, we examined three single nucleotide polymorphisms in 216 schizophrenic patients and 321 healthy controls. Signi¢cant associations of schizophrenia with the A allele of rs947267 (P ¼ 0.012) and haplotype A-A-G (rs2391191-rs947267-rs778294) (P ¼ 0.008) were found in early-onset schizophrenic patients. So did the same allele (P ¼ 0.034) and haplotype (P ¼ 0.009) as mentioned above in male patients. These ¢ndings suggest that the G72/G30 gene may modulate the age at onset and there might be a potential interaction between this locus and sex in the pathogenesis of schizophrenia. NeuroReport17:1899^1902 c 2006 Lippincott Williams & Wilkins.Keywords: age at onset, association study, G72/G30, polymorphism, schizophrenia
IntroductionSchizophrenia is a major psychiatric disorder that affects almost 1% of the world's population and accounts for about 2.5% of healthcare costs [1]. Symptoms usually begin in late adolescence or early adulthood. Involvement of neurodevelopmental mechanism, especially glutamatergic transmission via N-methyl-D-aspartate receptors and synaptic plasticity in schizophrenia, has been recently suggested, on the basis of several lines of evidence [2]. Linkage analyses on diverse samples have provided accumulating evidence that chromosome 13q32-q33 may be involved in susceptibility to schizophrenia. A meta-analysis of genomewide linkage studies further identified 13q32-q33 as significantly linked to schizophrenia [3].Chumakov et al.[4] first reported that genetic variations near G72 (MIN 607408) and G30 (MIN 607415) locus on 13q34 were associated with schizophrenia in FrenchCanadian and Russian cohorts. G72 and G30 overlap on complementary chromosomal strands and are therefore transcribed in opposite directions. By yeast two-hybrid experiments, Chumakov et al.[4] also identified that the G72 protein interacts with the enzyme D-amino acid oxidase (MIN 124050), which regulates glutamatergic signaling through an N-methyl-D-aspartate receptor pathway. Gene expression analysis of G72 and G30 exhibited correlations between expression levels of the G72 and G30 genes, as well as a tendency toward overexpression of G72 mRNA in schizophrenic post-mortem dorsolateral prefrontal cortex of 44 schizophrenic patients compared with 44 control participants [5].Hattori et al. [6] suggested that a susceptibility variant for both bipolar illness and schizophrenia exists in the vicinity of the G72/G30 gene in two series of pedigrees. Findings from several subsequent studies tend to advance a role for G72/G30 in the overall risk for schizophrenia and bipolar disorder from various populations, including a metaanalysis study and a research based on a sample of childonset schizophrenia [7][8][9][10][11][12][13][14]. The majority of replication studies have, however, been inconsistent with respect to the associated alleles or haplotypes. Moreover, negative associations of G72/G30 pol...